Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 168
The Years Ahead in Biomedical HIV Prevention Research
This graphic shows the updated status of large-scale prevention trials through the end of 2024.
Years Ahead in HIV Prevention Research: Time to Market
This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.
Prevention Option:
Vaccine Development History
A graphic showing the duration between discovery of the microbiologic cause of selected infectious diseases and the development of a vaccine.
Prevention Option:
HIV Vaccine Research
HIV vaccine research is a multifaceted endeavor that requires collaboration across many disciplines to develop a vaccine that protects people from HIV infection. The graphic outlines the different areas of research that are being pursued, including vaccine platforms, immune system research, clinical research capacity, and community engagement.
Prevention Option:
Getting the COVID-19 Vaccines We Need
As of March 2023, the World Health Organization reported that there are 199 COVID-19 vaccines in pre-clinical development, and 183 in clinical trials. Most are injectable; but 16 candidates are intranasal, 5 are oral, 2 are inhalable, and 1 is an...
Prevention Option:
How Do mRNA-Based COVID-19 Vaccines Work?
A detailed graphic showing the biological mechanisms by which mRNA vaccines work.
Prevention Option:
Other mRNA Vaccines in Development
mRNA technology is currently being studied for many different uses.
Prevention Option:
Vaccine Manufacturing is a Multi-Stage Process Often Requires Extensive Collaboration
This graphic highlights the extensive and complex process of vaccine production, encompassing initial design, drug development, large-scale manufacturing, the creation of administration devices, and finally, distribution.
Prevention Option:
From the Lab to the Jab
From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.
Prevention Option:
Local Vaccine Production: Harnessing Its Potential for Equity
This issue brief on local vaccine production covers the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.
Prevention Option:
showing 1-10 of 168